NCT06457178 Investigation of the Effect of Acceptance and Commitment Therapy-Based Intervention in Oncology Patients
| NCT ID | NCT06457178 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Istanbul University - Cerrahpasa |
| Condition | Acceptance and Commitment Therapy |
| Study Type | INTERVENTIONAL |
| Enrollment | 75 participants |
| Start Date | 2025-06-01 |
| Primary Completion | 2025-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 75 participants in total. It began in 2025-06-01 with a primary completion date of 2025-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to investigate the effectiveness of Acceptance and Commitment Therapy Based Intervention for Oncology Patients. The main questions it aims to answer are: * Does the Acceptance and Commitment to Therapy-Based Intervention for Oncology Patients affect the level of psychological distress? * Does the Acceptance and Commitment to Therapy-Based Intervention for Oncology Patients affect the level of reintegration into normal life? Researchers will compare Acceptance and Commitment Therapy-Based Intervention for Oncology Patients (ACT) to Psychoeducation for Oncology Patients and routine care (with no specific intervention) to see if Acceptance and Commitment Therapy-Based Intervention for Oncology Patients is effective in psychological distress and reintegration into normal living.
Eligibility Criteria
Inclusion Criteria: * 18 years of age or older, * Being able to read and write, * Receiving oncologic treatment, * Being diagnosed with breast cancer, * To know about Medical Diagnosis, * Being in stage 1, 2 or 3 of the disease, * Receiving outpatient chemotherapy treatment only, * Internet access and computer skills to participate in online group interviews, * Low to moderate scores on the brief psychological resilience scale, Exclusion Criteria: * Having serious psychiatric or cognitive impairments that limit adherence to group sessions, * Having a physical disability that may make it difficult to participate in group sessions, * Failure to attend sessions regularly and absenteeism, * Currently being in a psychoeducation/psychotherapy group
Contact & Investigator
Dilara Sert Kasım, M.Sc.
PRINCIPAL INVESTIGATOR
Istanbul University - Cerrahpasa
Frequently Asked Questions
Who can join the NCT06457178 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Acceptance and Commitment Therapy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06457178 currently recruiting?
Yes, NCT06457178 is actively recruiting participants. Contact the research team at dilara.sert10@ogr.iuc.edu.tr for enrollment information.
Where is the NCT06457178 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT06457178 clinical trial?
NCT06457178 is sponsored by Istanbul University - Cerrahpasa. The principal investigator is Dilara Sert Kasım, M.Sc. at Istanbul University - Cerrahpasa. The trial plans to enroll 75 participants.